Diagnosis and Management of Autoimmune Pancreatitis

Overview

Journal Curr Treat Options Gastroenterol

Specialty Gastroenterology

Date 2017 Aug 27

PMID 28842855

Citations 8

Authors

Phil A Hart

Somashekar G Krishna

Kazuichi Okazaki

Affiliations

Soon will be listed here.

Abstract

Although autoimmune pancreatitis is a relatively uncommon pancreatic disorder, it is an important consideration in the differential diagnosis of jaundice and pancreatic masses to avoid unnecessary surgical resection. The clinical diagnosis of autoimmune pancreatitis involves considering multiple pieces of information including the pancreatic imaging, serum IgG4 level, presence of characteristic other involvement, and histologic findings. Unlike other pancreatic disorders, this condition rapidly responds to treatment with steroids. In the more common disease subtype (type 1 autoimmune pancreatitis) disease relapses can occur necessitating the use of maintenance treatment with low-dose steroids, steroid-sparing immunomodulators, or rituximab. This chapter reviews the diagnosis and treatment of the autoimmune pancreatitis subtypes.

Citing Articles

Unraveling the relationship between autoimmune pancreatitis type 2 and inflammatory bowel disease: Results from two centers and systematic review of the literature.

Nikolic S, Lanzillotta M, Panic N, Brismar T, Moro C, Capurso G United European Gastroenterol J. 2022; 10(5):496-506.

PMID: 35526270 PMC: 9427095. DOI: 10.1002/ueg2.12237.

Autoimmune pancreatitis: What we know so far.

Masood M JGH Open. 2022; 6(1):3-10.

PMID: 35071782 PMC: 8762623. DOI: 10.1002/jgh3.12688.

Multifocal autoimmune pancreatitis: A retrospective study in a single tertiary center of 26 patients with a 20-year literature review.

Huang X, Shi Z, Ma C World J Gastroenterol. 2021; 27(27):4429-4440.

PMID: 34366614 PMC: 8316903. DOI: 10.3748/wjg.v27.i27.4429.

Diagnostic yield of endoscopic ultrasound-guided tissue acquisition in autoimmune pancreatitis: a systematic review and meta-analysis.

Facciorusso A, Barresi L, Cannizzaro R, Antonini F, Triantafyllou K, Tziatzios G Endosc Int Open. 2021; 9(1):E66-E75.

PMID: 33403238 PMC: 7775812. DOI: 10.1055/a-1293-7279.

PrescrAIP: A Pan-European Study on Current Treatment Regimens of Auto-Immune Pancreatitis.

Lanzillotta M, Vinge-Holmquist O, Overbeek K, Poulsen J, Demirci A, Macinga P Front Med (Lausanne). 2020; 7:408.

PMID: 32850908 PMC: 7419461. DOI: 10.3389/fmed.2020.00408.

References

Kamisawa T, Chari S, Giday S, Kim M, Chung J, Lee K . Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas. 2011; 40(6):809-14. DOI: 10.1097/MPA.0b013e3182258a15. View

Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N . Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995; 40(7):1561-8. DOI: 10.1007/BF02285209. View

Chari S, Singer M . The problem of classification and staging of chronic pancreatitis. Proposals based on current knowledge of its natural history. Scand J Gastroenterol. 1994; 29(10):949-60. DOI: 10.3109/00365529409094869. View

Zamboni G, Luttges J, Capelli P, Frulloni L, Cavallini G, Pederzoli P . Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004; 445(6):552-63. DOI: 10.1007/s00428-004-1140-z. View

Kamisawa T, Shimosegawa T, Okazaki K, Nishino T, Watanabe H, Kanno A . Standard steroid treatment for autoimmune pancreatitis. Gut. 2009; 58(11):1504-7. DOI: 10.1136/gut.2008.172908. View

Huggett M, Culver E, Kumar M, Hurst J, Rodriguez-Justo M, Chapman M . Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol. 2014; 109(10):1675-1683. PMC: 4552254. DOI: 10.1038/ajg.2014.223. View

Hart P, Kamisawa T, Brugge W, Chung J, Culver E, Czako L . Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2012; 62(12):1771-6. PMC: 3862979. DOI: 10.1136/gutjnl-2012-303617. View

Hart P, Chari S . Preventing disease relapses in autoimmune pancreatitis with maintenance steroids: are we there yet?. Gut. 2016; 66(3):394-396. DOI: 10.1136/gutjnl-2016-312738. View

Hart P, Smyrk T, Chari S . Lymphoplasmacytic sclerosing pancreatitis without IgG4 tissue infiltration or serum IgG4 elevation: IgG4-related disease without IgG4. Mod Pathol. 2014; 28(2):238-47. DOI: 10.1038/modpathol.2014.91. View

10.

Kamisawa T, Okazaki K, Kawa S, Ito T, Inui K, Irie H . Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014; 49(6):961-70. DOI: 10.1007/s00535-014-0945-z. View

11.

Notohara K, Burgart L, Yadav D, Chari S, Smyrk T . Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003; 27(8):1119-27. DOI: 10.1097/00000478-200308000-00009. View

12.

Hart P, Topazian M, Witzig T, Clain J, Gleeson F, Klebig R . Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2012; 62(11):1607-15. DOI: 10.1136/gutjnl-2012-302886. View

13.

Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N . Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991; 22(4):387-95. DOI: 10.1016/0046-8177(91)90087-6. View

14.

Ryu J, Chung J, Park S, Lee J, Lee K, Lee W . Review of 67 patients with autoimmune pancreatitis in Korea: a multicenter nationwide study. Pancreas. 2008; 37(4):377-85. DOI: 10.1097/MPA.0b013e31817a0914. View

15.

Moon S, Kim M, Park D, Hwang C, Park S, Lee S . Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut. 2008; 57(12):1704-12. DOI: 10.1136/gut.2008.150979. View

16.

Masamune A, Nishimori I, Kikuta K, Tsuji I, Mizuno N, Iiyama T . Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut. 2016; 66(3):487-494. DOI: 10.1136/gutjnl-2016-312049. View

17.

Hart P, Zen Y, Chari S . Recent Advances in Autoimmune Pancreatitis. Gastroenterology. 2015; 149(1):39-51. DOI: 10.1053/j.gastro.2015.03.010. View

18.

Detlefsen S, Zamboni G, Frulloni L, Feyerabend B, Braun F, Gerke O . Clinical features and relapse rates after surgery in type 1 autoimmune pancreatitis differ from type 2: a study of 114 surgically treated European patients. Pancreatology. 2012; 12(3):276-83. DOI: 10.1016/j.pan.2012.03.055. View

19.

Sah R, Chari S, Pannala R, Sugumar A, Clain J, Levy M . Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010; 139(1):140-8. DOI: 10.1053/j.gastro.2010.03.054. View

20.

Okazaki K, Chari S, Frulloni L, Lerch M, Kamisawa T, Kawa S . International consensus for the treatment of autoimmune pancreatitis. Pancreatology. 2016; 17(1):1-6. DOI: 10.1016/j.pan.2016.12.003. View